STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1179 by analyst upside · 2026-08-12
ALMS
Alumis Inc.
Healthcare · Market Cap $3B · P/E 0x
ANALYST PRICE TARGET
+59.0%
implied upside to consensus target
Current Price $25.37
Consensus Target $40.33
Bull Target $55.0
Bear Target $25.0
Analysts Covering 9
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
7
Hold
1
Sell
0
52-Week Low $3.76
52-Week High $31.35
YTD Return +183.3%
FUNDAMENTALS
Market Cap $3B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-1.78
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $8M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $3.76
52-Week High $31.35
Current Price $25.37
Bear Target $25.0
Bull Target $55.0
● Now $25.37 ● Target $40.33
TRADING DATA
Avg Volume 1.3M
YTD Return +183.3%
Analyst Count 9
Consensus Buy
Upside to Target +59.0%
Last Updated 2026-08-12

ANALYST SUMMARY

Alumis Inc. (ALMS) is currently trading at $25.37 with a Wall Street consensus price target of $40.33, implying potential upside of 59.0% over the next 12 months. 9 analysts currently cover ALMS, with a consensus rating of Buy - 89% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $55.0, while the most cautious has a target of $25.0.

ALMS operates in the Healthcare sector with a market capitalisation of $3B. The stock is up 183.3% year-to-date and is currently trading near the upper end of its 52-week range of $3.76 – $31.35.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ALMS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Chardan Capital - Reiterated
Buy → Buy 2026-05-19 33% win rate (6 calls)
Wells Fargo - Reiterated
Overweight → Overweight 2026-05-15 Building track record
Guggenheim - Reiterated
Buy → Buy 2026-05-15 62% win rate (8 calls)
HC Wainwright & Co. ↓ Downgrade
Buy → Neutral 2026-05-15 31% win rate (48 calls)
Oppenheimer - Reiterated
Outperform → Outperform 2026-03-30 14% win rate (7 calls)
Chardan Capital - Reiterated
Buy → Buy 2026-03-30 33% win rate (6 calls)
HC Wainwright & Co. - Reiterated
Buy → Buy 2026-03-30 31% win rate (48 calls)
Morgan Stanley - Reiterated
Overweight → Overweight 2026-03-20 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
46
out of 100
Coverage depth
18/30
Consensus clarity
6/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →